January 12-15, 2026 | San Francisco Marriott Marquis, CA
Small molecule in the GLP tox phase against a new mechanism inducing tissue regeneration in heart failure (HFrEF and HFpEF), kidney failure, neurodegenerative diseases, fibrosis, diabetes.